FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder August 17, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder